Literature DB >> 6359423

Quantitative assessment of deranged hepatic function: a missed opportunity?

J Bircher.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6359423     DOI: 10.1055/s-2008-1040780

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  11 in total

1.  Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.

Authors:  Claudio A Redaelli; Jean-François Dufour; Markus Wagner; Martin Schilling; Jürg Hüsler; Lukas Krähenbühl; Markus W Büchler; Jürg Reichen
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

Review 2.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

3.  Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration.

Authors:  A E Muñoz; C Miguez; M Rubio; M Bartellini; D Levi; A Podestá; V Niselman; R Terg
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

4.  Preliminary studies of a canine 13C-aminopyrine demethylation blood test.

Authors:  E M Moeller; J M Steiner; D A Williams; P D Klein
Journal:  Can J Vet Res       Date:  2001-01       Impact factor: 1.310

5.  Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis.

Authors:  C Merkel; M Bolognesi; S Bellon; S Bianco; B Honisch; H Lampe; P Angeli; A Gatta
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

6.  Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity.

Authors:  M Abei; E Tanaka; N Tanaka; Y Matsuzaki; T Ikegami; A Ishikawa; T Osuga
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

7.  Treatment of liver disease with malotilate. A pharmacokinetic and pharmacodynamic phase II study in cirrhosis.

Authors:  M Bührer; J Y Le Cotonnec; M Wermeille; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Use of a 13C-aminopyrine blood test: first clinical impressions.

Authors:  Deirdre Chiaramonte; Jörg M Steiner; John D Broussard; Keith Baer; Sheila Gumminger; Erik M Moeller; David A Williams; Renée Shumway
Journal:  Can J Vet Res       Date:  2003-07       Impact factor: 1.310

9.  Urinary caffeine metabolites in man. Age-dependent changes and pattern in various clinical situations.

Authors:  D Ullrich; D Compagnone; B Münch; A Brandes; H Hille; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

10.  Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease.

Authors:  I R Corbin; R Buist; J Peeling; M Zhang; J Uhanova; G Y Minuk
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.